HIGHLIGHTS
- who: Francesco Menzella et al. from the (UNIVERSITY) have published the paper: Immunological Aspects Related to Viral Infections in Severe Asthma and the Role of Omalizumab, in the Journal: Biomedicines 2021, 9, 348. of 20/04/2020
- what: The MATERIAL study had the main purpose to determine if mepolizumab 750 mg intravenous (IV) could change the immune and inflammatory responses to rhinovirus type 16 (RV16) in mild asthma.
- how: The results showed that mepolizumab had no clinical effects in terms of immune_response to this infection . The results showed that in patients in treatment . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.